Granulocito-aferesis en Behçet ocular refractario al tratamiento médico

  1. O García García
  2. A Vidaller Palacín
  3. J Muñoz Sánchez
  4. G Roca Linares
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2004

Volume: 79

Issue: 7

Pages: 335-340

Type: Article

DOI: 10.4321/S0365-66912004000700007 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Archivos de la Sociedad Española de Oftalmologia

Sustainable development goals

Abstract

Objective: To assess the feasibility of granulocyte apheresis (GCAP) in patients with Ocular Behçet’s Disease (BD) resistant to immunosuppressive therapy (prednisone, cyclosporin, azathyoprine or mycophenolate mofetil). Methods: Prospective observational study of five cases, carried out in a university centre. Four patients were resistant to medical treatment and one refused immunosuppressive drugs. The intervention procedure consisted of an extracorporeal GCAP using a column filled with cellulose acetate beads (Adacolumn, JIMRO, Takasaki, Japan). All patients received underwent a schedule of therapy of five sessions, once a week for five consecutive weeks. Visual acuity (Snellen lines), the degree of intraocular inflammation and doses of immunosuppressive therapy were measured and observed every week. Results: Visual acuity improved in the five cases. Intraocular inflammation was measured and observed in every case, relapses were avoided, and treatment with prednisone was reduced by more than half of the initial dose (average reduction 52.7%, SD 14). Conclusions: GCAP has been shown to be safe and effective as a new therapy in five cases of Ocular Behçet’s Disease refractory to medical treatment. Further research is needed in order to confirm the promising results of these initial investigations.

Bibliographic References

  • Sakane, T, Takeno, M, Suzuki, N, Inaba, G.. (1999). Behcet´s disease. N Engl J Med. 341. 1284-1291
  • Dick, A D, Azim, M, Forrester, JV.. (1997). Immunosuppresive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol. 81. 1107-1112
  • Hanai, H, Watanabe, F, Takeuchi, K, Iida, T, Iwaoka, Y, Saniabadi, A. (2003). Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol. 1. 28-35
  • Kashiwagi, N, Hirata, I, Kasukawa, R.. (1998). A role of granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher. 2. 134-141
  • Kashiwagi, N, Sugimura, K, Koiwai, H, Yamamoto, H, Yoshikawa, T, Saniabadi, AR. (2002). Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci. 47. 1334-1341
  • (1990). Criteria for the diagnosis of Behcet´s disease. Lancet. 335. 1078-1080
  • Shimoyama, T, Sawada, K, Hiwatashi, N, Sawada, T, Matsueda, K, Munakata, A. (2001). Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis. 16. 1-9
  • Hanai, H, Watanabe, F, Saniabadi, AR, Matsushitai, I, Takeuchi, K, Iida, T.. (2002). Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci. 47. 2349-2353
  • Matsui, T, Nishimura, T, Matake, H, Ohta, T, Sakurai, T, Yao, T.. (2003). Granulocytapheresis for Crohn´s disease: a report on seven refractory patients. Am J Gastroenterol. 98. 511-512
  • Hanai, H, Watanabe, F, Takeuchi, K, Iida, T, Yamada, M, Iwaoka, Y. (2003). Leukocite adsorptive apheresis for the treatment of active ulcerative colitis: a prospective uncontrolled pilot study. Clin Gastroenterol Hepatol. 1. 28-35
  • Sakane, T, Takeno, M, Suzuki, N, Inaba, G.. (1999). Behcet’s disease. N Engl J Med. 341. 1284-1291
  • Boyd, SR, Young, S, Lightman, S.. (2001). Immunopathology of the non-infectious posterior and intermediate uveitides. Surv Ophthalmol. 46. 209-233
  • Benezra, D, Maftzir, G, Barak, V.. (1997). Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behcet disease. Am J Ophthalmol. 123. 593-598
  • Rembacken, BJ, Newbould, HE, Richards, SJ, Misbah, SA, Dixon, ME, Chalmers, DM. (1998). Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect. Ther Apher. 2. 93-96
  • Tsukada, Y, Nakamura, T, Iimura, M, Iizuka, BE, Mayashi, N.. (2002). Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Am J Gastroenterol.. 97. 2820-2828
  • Yamaji, K, Tsuda, H, Hashimoto, H.. (2001). Current topics on cytapheresis technologies. Ther Apher. 5. 287-292
Data source: Dialnet